Arkolith/Insider Trading/DNLI/Form 4

Krognes Steve E.

DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Jan 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$69K
Net Open-Market Flow
-$69K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2025Sell(S)3K$20.81$69K26K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-25-000048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML